Get the Stockscreener App
0.5366
4.21%
-0.0236
Rallybio Corp stock is traded at $0.5366, with a volume of 237.66K.
It is down -4.21% in the last 24 hours and up +14.12% over the past month.
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
See More
Previous Close:
$0.5602
Open:
$0.5434
24h Volume:
237.66K
Relative Volume:
0.09
Market Cap:
$22.42M
Revenue:
-
Net Income/Loss:
$-74.56M
P/E Ratio:
-0.293
EPS:
-1.8316
Net Cash Flow:
$-60.27M
1W Performance:
-14.28%
1M Performance:
+14.12%
6M Performance:
-27.49%
1Y Performance:
-54.91%
1-Day Range:
$0.5253
$0.5711
1-Week Range:
$0.5253
$0.63
52-Week Range:
$0.2201
$1.2401
Rallybio Corp Stock (RLYB) Company Profile
Name
Rallybio Corp
Sector
Industry
Phone
203- 859-3820
Address
234 CHURCH STREET, NEW HAVEN
Compare RLYB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.5366 | 23.41M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-15-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-07-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-17-23 | Initiated | H.C. Wainwright | Buy |
| Apr-10-23 | Initiated | Wedbush | Outperform |
| Dec-09-22 | Initiated | JP Morgan | Overweight |
| Feb-22-22 | Initiated | JMP Securities | Mkt Outperform |
| Aug-23-21 | Initiated | Cowen | Outperform |
| Aug-23-21 | Initiated | Evercore ISI | Outperform |
| Aug-23-21 | Initiated | Jefferies | Buy |
View All
Rallybio Corp Stock (RLYB) Latest News
Rallybio Corporation’s volatility index tracking explainedPortfolio Return Summary & Low Drawdown Momentum Ideas - Newser
What the charts say about Rallybio Corporation todayNew Guidance & Intraday High Probability Alerts - Newser
Tools to monitor Rallybio Corporation recovery probabilityGDP Growth & Stock Portfolio Risk Control - Newser
How high can Rallybio Corporation stock goRecession Risk & Long-Term Safe Investment Plans - Newser
Detecting price anomalies in Rallybio Corporation with AI2025 Technical Overview & Fast Entry High Yield Stock Tips - Newser
Analyzing drawdowns of Rallybio Corporation with statistical toolsMarket Sentiment Review & Long-Term Growth Plans - Newser
Regression analysis insights on Rallybio Corporation performance2025 Sector Review & Low Risk High Reward Ideas - Newser
Automated trading signals detected on Rallybio CorporationTrade Entry Report & Expert Approved Trade Ideas - Newser
Is Rallybio Corporation meeting your algorithmic filter criteriaMarket Risk Report & Long-Term Growth Stock Strategies - Newser
Will Rallybio Corporation see short term momentumFed Meeting & Daily Risk Controlled Trade Plans - Newser
Can Rallybio Corporation recover in the next quarterMarket Movement Recap & High Accuracy Buy Signal Tips - Newser
Momentum divergence signals in Rallybio Corporation chartStop Loss & Weekly High Potential Stock Alerts - Newser
Real time scanner hits for Rallybio Corporation explainedEntry Point & Weekly Breakout Opportunity Watchlist - Newser
What analysts say about Rallybio Corporation stock2025 Growth vs Value & Advanced Swing Trade Entry Plans - sundaytimes.kr
Rallybio Corporation stock volume spike explained2025 Dividend Review & Weekly Market Pulse Updates - Newser
Analyzing recovery setups for Rallybio Corporation investorsM&A Rumor & Safe Entry Point Identification - Newser
Key metrics from Rallybio Corporation’s quarterly data2025 Year in Review & Verified Stock Trade Ideas - Newser
Should you wait for a breakout in Rallybio CorporationMarket Performance Summary & Daily Entry Point Alerts - Newser
Rallybio Granted Extension for Nasdaq Compliance - TipRanks
Can Rallybio Corporation be the next market leader2025 Stock Rankings & Smart Allocation Stock Tips - sundaytimes.kr
Relative strength of Rallybio Corporation in sector analysisMarket Rally & Weekly High Return Opportunities - Newser
Historical volatility pattern of Rallybio Corporation visualizedMarket Volume Summary & Low Risk Entry Point Guides - Newser
Rallybio Corporation Flashes Rebound Signal in Oversold Condition2025 Fundamental Recap & High Accuracy Swing Entry Alerts - beatles.ru
Rallybio Corp Stock (RLYB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):